Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.78 USD | -1.58% | -3.95% | -41.14% |
04-25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
04-25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.14% | 781M | |
+3.25% | 106B | |
+7.71% | 23.47B | |
-15.07% | 21.9B | |
-6.22% | 18.77B | |
-37.26% | 17.85B | |
-8.41% | 16.78B | |
+7.88% | 14.41B | |
+38.49% | 12.86B | |
+318.32% | 8.78B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained